0

    531592

    GENPHARMA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    GENPHARMASEC LIMITED Share Price Today

    Investment Returns

    Over 1 Month -3.47% Over 3 Months -3.47% Over 6 Months -17.77% Over 1 Year -46.11%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    GENPHARMASEC LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 61.50
    • P/E Ratio (TTM) 11.10
    • Beta 1.09
    • Book Value / share 1.29
    • Return on equity 3.59%
    • EPS (TTM) 0.10
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 2.32
    info icon alternate text

    GENPHARMASEC LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 51.66
    Operating Expense 50.42
    Net Profit 2.32
    Net Profit Margin (%) 4.49
    Earnings Per Share (EPS) 0.04
    EBITDA 3.19
    Effective Tax Rate (%) 18.88
    Particulars DEC 2025 (Values in Cr)
    Revenue 36.01
    Operating Expense 36.94
    Net Profit 0.76
    Net Profit Margin (%) 2.11
    Earnings Per Share (EPS) 0.01
    EBITDA 0.75
    Effective Tax Rate (%) -55.10
    Particulars SEP 2025 (Values in Cr)
    Revenue 31.56
    Operating Expense 31.18
    Net Profit 0.82
    Net Profit Margin (%) 2.59
    Earnings Per Share (EPS) 0.01
    EBITDA 1.50
    Effective Tax Rate (%) 40.57
    Particulars JUN 2025 (Values in Cr)
    Revenue 12.11
    Operating Expense 11.23
    Net Profit 1.56
    Net Profit Margin (%) 12.88
    Earnings Per Share (EPS) 0.03
    EBITDA 1.83
    Effective Tax Rate (%) 8.77
    Particulars MAR 2025 (Values in Cr)
    Revenue 13.56
    Operating Expense 14.65
    Net Profit -0.23
    Net Profit Margin (%) -1.69
    Earnings Per Share (EPS) 0.01
    EBITDA 0.06
    Effective Tax Rate (%) -475.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 131.35
    Operating Expense 129.78
    Net Profit 5.45
    Net Profit Margin (%) 4.14
    Earnings Per Share (EPS) 0.10
    EBITDA 7.29
    Effective Tax Rate (%) 15.37
    Particulars MAR 2025 (Values in Cr)
    Revenue 32.96
    Operating Expense 32.62
    Net Profit 2.80
    Net Profit Margin (%) 8.49
    Earnings Per Share (EPS) 0.04
    EBITDA 4.18
    Effective Tax Rate (%) 25.92
    Particulars MAR 2024 (Values in Cr)
    Revenue 30.41
    Operating Expense 30.65
    Net Profit 0.05
    Net Profit Margin (%) 0.16
    Earnings Per Share (EPS) -0.01
    EBITDA 0.88
    Effective Tax Rate (%) 89.36
    Particulars MAR 2023 (Values in Cr)
    Revenue 25.52
    Operating Expense 25.34
    Net Profit 1.12
    Net Profit Margin (%) 4.38
    Earnings Per Share (EPS) 0.04
    EBITDA 0.36
    Effective Tax Rate (%) -299.99
    Particulars MAR 2022 (Values in Cr)
    Revenue 27.32
    Operating Expense 27.86
    Net Profit -0.21
    Net Profit Margin (%) -0.76
    Earnings Per Share (EPS) -0.01
    EBITDA -0.43
    Effective Tax Rate (%) 52.27
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 1.18
    ROE % 1.85
    ROCE % 3.28
    Total Debt to Total Equity 0.07
    EBITDA Margin 9.31
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1.16
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.09
    EBITDA Margin 2.30
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 0.55
    ROE % 5.63
    ROCE % 1.48
    Total Debt to Total Equity 0.20
    EBITDA Margin 1.41
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 1.20
    ROE % 3.59
    ROCE % 5.18
    Total Debt to Total Equity 0.05
    EBITDA Margin 11.74
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1.17
    ROE % 0.11
    ROCE % 1.81
    Total Debt to Total Equity 0.08
    EBITDA Margin 2.86
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 0.55
    ROE % 6.35
    ROCE % 1.77
    Total Debt to Total Equity 0.10
    EBITDA Margin 1.41
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 0.56
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -1.57
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 0.75
    ROE % 6.35
    ROCE % 7.61
    Total Debt to Total Equity 0.00
    EBITDA Margin 7.13
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 5.27
    Total Assets 79.89
    Total Liabilities 79.89
    Total Equity 65.27
    Share Outstanding 55
    Price to Book Ratio 1.58
    Return on Assets (%) 1.54
    Return on Capital (%) 1.8
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 18.83
    Total Assets 71.12
    Total Liabilities 71.12
    Total Equity 64.53
    Share Outstanding 55
    Price to Book Ratio 1.91
    Return on Assets (%) -0.23
    Return on Capital (%) -0.25
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.99
    Total Assets 19.87
    Total Liabilities 19.87
    Total Equity 15.33
    Share Outstanding 27
    Price to Book Ratio 5.65
    Return on Assets (%) 5.65
    Return on Capital (%) 6.11
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 5.14
    Total Assets 79.09
    Total Liabilities 79.09
    Total Equity 66.54
    Share Outstanding 55
    Price to Book Ratio 1.58
    Return on Assets (%) 3.12
    Return on Capital (%) 3.54
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 18.57
    Total Assets 70.47
    Total Liabilities 70.47
    Total Equity 64.56
    Share Outstanding 55
    Price to Book Ratio 1.91
    Return on Assets (%) 0.06
    Return on Capital (%) 0.07
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.99
    Total Assets 19.87
    Total Liabilities 19.87
    Total Equity 15.33
    Share Outstanding 27
    Price to Book Ratio 5.65
    Return on Assets (%) 5.65
    Return on Capital (%) 6.11
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.60
    Total Assets 21.65
    Total Liabilities 21.65
    Total Equity 15.36
    Share Outstanding 27
    Price to Book Ratio 9.82
    Return on Assets (%) -0.96
    Return on Capital (%) -1.36
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 3.53
    Total Assets 27.81
    Total Liabilities 27.81
    Total Equity 20.66
    Share Outstanding 27
    Price to Book Ratio 10.68
    Return on Assets (%) 4.51
    Return on Capital (%) 6.09
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.88
    Cash from Operations 3.06
    Cash from Investing -15.29
    Cash from Financing -1.24
    Net change in Cash -13.56
    Free Cash Flow 8.76
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.25
    Cash from Operations -2.90
    Cash from Investing -28.06
    Cash from Financing 47.84
    Net change in Cash 16.83
    Free Cash Flow -2.88
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.28
    Cash from Operations -3.32
    Cash from Investing 0.36
    Cash from Financing 3.08
    Net change in Cash 0.38
    Free Cash Flow -3.30
    Particulars MAR 2025 (Values in Cr)
    Net Income 3.44
    Cash from Operations 3.49
    Cash from Investing -16.45
    Cash from Financing -0.43
    Net change in Cash -13.43
    Free Cash Flow 3.50
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.46
    Cash from Operations -2.23
    Cash from Investing -29.03
    Cash from Financing 47.89
    Net change in Cash 16.58
    Free Cash Flow -2.21
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.28
    Cash from Operations -3.32
    Cash from Investing 0.36
    Cash from Financing 3.08
    Net change in Cash 0.38
    Free Cash Flow -3.30
    Particulars MAR 2022 (Values in Cr)
    Net Income -0.44
    Cash from Operations -2.31
    Cash from Investing 0.41
    Cash from Financing 0.00
    Net change in Cash -1.92
    Free Cash Flow -2.23
    Particulars MAR 2021 (Values in Cr)
    Net Income 1.50
    Cash from Operations -1.78
    Cash from Investing -1.41
    Cash from Financing 4.50
    Net change in Cash 0.95
    Free Cash Flow -1.77
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AEGIS LOGISTICS LIMITED 1325.65 51.80 7.68 46530.32 576.00 1347.75
    KOTHARI INDUSTRIAL CORP L 156.30 0.00 8.06 1688.38 142.00 624.95
    OSWAL AGRO MILLS LTD. 41.12 0.00 0.61 551.95 33.50 94.50
    DHUNSERI VENTURES LIMITED 237.65 9.13 0.25 832.25 176.20 386.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AEGIS LOGISTICS LIMITED 1325.65 49.32 13.45 46530.32 576.00 1347.75
    UTIQUE ENTERPRISES LIMITED 3.93 11.56 0.30 21.88 3.20 6.40
    COMPUTER POINT LTD. 3.95 0.00 0.35 11.85 3.39 6.20
    KOTHARI INDUSTRIAL CORP L 156.30 0.00 6.74 1688.38 142.00 624.95

    GENPHARMASEC LIMITED shareholding pattern

    Holding
    70.02%
    29.97%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    GENPHARMASEC LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1.11 -2.63 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 1.10
    • 26 Days 1.10
    • 10 Days 1.10
    • 50 Days 1.20
    • 12 Days 1.10
    • 100 Days 1.20
    • 20 Days 1.10
    • 200 Days 1.40
    1.14 PIVOT
    First Support 1.09 First Resistance 1.19 Second Support 1.04 Second Resistance 1.24 Third Support 0.99 Third Resistance 1.29
    RSI 45.39 ADX 13.22 MACD -0.02 Williams % R -50.00 Commodity Channel Index (CCI) -9.82
    Date 2026-07-03 Week 257133.00 Same Day 154186.00 Month 259904.00
    1 Year 1.10 3 Year 0.84
    Over 1 Month
    -3.47% down
    Over 1 Year
    -46.11% down
    Over 3 Months
    -3.47% down
    Over 3 Years
    -18.88% down
    Over 6 Months
    -17.77% down
    Over 5 Years
    -28.83% down

    GENPHARMASEC LIMITED Corporate Actions

    Ex-Date Old FV NEW FV Record Date
    11 Apr 2019 10.0 1.0 12 Apr 2019

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Genpharmasec Ltd?

    Answer Field

    Genpharmasec Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1.11 as on Jul 03 2026 03:29 PM.

    What is the Market Cap of Genpharmasec Ltd Share?

    Answer Field

    The market cap of Genpharmasec Ltd for NSE ₹ 0.00 & for BSE ₹ 61.50 as on Jul 03 2026 03:29 PM.

    What is the 52 Week High and Low of Genpharmasec Ltd?

    Answer Field

    The 52 Week High and Low of Genpharmasec Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 2.20 and ₹ 0.75.

    What is 1 year return for Genpharmasec Ltd?

    Answer Field

    The 1 year returns on the stock has been -46.11%.

    What is the P/E Ratio of Genpharmasec Ltd Share?

    Answer Field

    As on Jul 03 2026 03:29 PM the price-to-earnings (PE) ratio for Genpharmasec Ltd share is 11.10.

    What is the PB ratio of Genpharmasec Ltd Share?

    Answer Field

    As on Jul 03 2026 03:29 PM, the price-to-book (PB) ratio for Genpharmasec Ltd share is 1.29.

    How to Buy Genpharmasec Ltd Share?

    Answer Field

    You can trade in Genpharmasec Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Genpharmasec Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Genpharmasec Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Genpharmasec Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |